Alex Goldberg

Urban Outfitters Inc. (NASDAQ:URBN) and BioLineRx, Ltd. (NASDAQ:BLRX) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/17/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Urban Outfitters Inc. (NASDAQ:URBN) and BioLineRx, Ltd. (NASDAQ:BLRX).

Urban Outfitters Inc. (NASDAQ:URBN) a company that engages in the retail and wholesale of general consumer products in the United States closed up in its previous session (+0.70%) on 2,641,785 shares traded after Urban Outfitters was upgraded to Buy from Neutral at Goldman. Urban Outfitters Inc. (NASDAQ:URBN) is currently up (+5.34%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Urban Outfitters Inc. (NASDAQ:URBN)

BioLineRx, Ltd. (NASDAQ:BLRX) a clinical stage biopharmaceutical development company that engages in identifying, in-licensing, and developing therapeutic candidates closed up in its previous session (+14.90%) on 2,374,508 shares traded after BioLineRx Announced Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment. BioLineRx, Ltd. (NASDAQ:BLRX) is currently up (+115.48%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about BioLineRx, Ltd. (NASDAQ:BLRX)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com